ICON Stock

ICON Financial Leverage

The Financial Leverage (Equity Multiplier) of ICON (ICLR) as of Aug 8, 2026 is 1.77. In the previous year, Financial Leverage (Equity Multiplier) was 1.77 — a change of -0.15% (lower).

Financial Leverage

1.77

YoY

-0.15%

Last updated:

Financial Leverage (Equity Multiplier) of ICON is 2026 1.77 . Financial Leverage (Equity Multiplier) of ICON was 2025 1.77 . It decreases by -0.15% lower compared to the previous year.
Access this data via the Eulerpool API

ICON Stock analysis

What does ICON do? ICON PLC is a global company specializing in clinical research and development of pharmaceuticals. The company was founded in 1990 and is headquartered in Dublin, Ireland. It was formed through the merger of several smaller companies. Today, ICON PLC is one of the world's leading companies in the field of clinical trials. ICON is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ICON stock

Financial Leverage (Equity Multiplier) of ICON is 1.77 in 2026.

Financial Leverage (Equity Multiplier) of ICON changed from 1.77 to 1.77, representing a -0.15% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) ICON since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s ICON with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Leverage — ICON

All Key Metrics — ICON